Fellow-Eye Comparison between Phaco-Microhook Ab-Interno Trabeculotomy and Phaco-iStent Trabecular Micro-Bypass Stent

The aim of this study is to compare the surgical efficacy and safety between microhook ab-interno trabeculotomy (µLOT) and iStent trabecular micro-bypass stent implantation when both were combined with cataract surgery in both eyes of patients. Sixty-four glaucomatous eyes (32 participants; mean age...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2021-05, Vol.10 (10), p.2129
Hauptverfasser: Takayanagi, Yuji, Ichioka, Sho, Ishida, Akiko, Tsutsui, Aika, Tanito, Masaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page 2129
container_title Journal of clinical medicine
container_volume 10
creator Takayanagi, Yuji
Ichioka, Sho
Ishida, Akiko
Tsutsui, Aika
Tanito, Masaki
description The aim of this study is to compare the surgical efficacy and safety between microhook ab-interno trabeculotomy (µLOT) and iStent trabecular micro-bypass stent implantation when both were combined with cataract surgery in both eyes of patients. Sixty-four glaucomatous eyes (32 participants; mean age, 75.9 ± 7.6 years; 15 men, 17 women) were included retrospectively. Intraocular pressure (IOP), number of antiglaucoma medications, best-corrected visual acuity (BCVA), anterior chamber flare (ACF) and corneal endothelial cell density (CECD) were evaluated preoperatively, as well as 2, 3, 6, and 12 months postoperatively. Surgical complications and interventions were compared between the procedures. The preoperative IOP and medications with µLOT (18.8 ± 5.7 mmHg and 3.0 ± 1.2, respectively) were higher than with the iStent (15.5 ± 3.4 mmHg and 2.7 ± 1.2, respectively) (p = 0.0001 and p = 0.0437, respectively). At 12 months, the µLOT values (12.6 ± 2.3 mmHg and 2.3 ± 0.9, respectively) were identical to iStent (12.8 ± 2.5 mmHg and 2.3 ± 0.9, respectively) (p = 0.0934 and p = 0.3251, respectively). At 12 months, the IOP decreased more with µLOT (6.2 mmHg, 29.5%) than iStent (2.7 mmHg, 15.6%) (p = 0.0003). The decrease in medications was greater with µLOT (0.7) than iStent (0.4) (p = 0.0437). Survival rate of IOP control ≤15 mmHg and IOP reduction ≥20% was significantly higher after µLOT (40.6% at 12 months) than iStent (18.8%) (p = 0.0277). The frequency of layered hyphema was significantly greater with µLOT (8 eyes, 25%) than iStent (0 eyes, 0%) (p = 0.0048). The increase in the ACF at 2 weeks postoperatively was significantly greater with µLOT than iStent (p = 0.0156), while changes in the BCVA and CECD were identical between groups. The fellow-eye comparison showed that the IOP reduction was greater with µLOT than iStent when combined with cataract surgery.
doi_str_mv 10.3390/jcm10102129
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8157143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2536480435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-d1a8de935942a2c8b46865620a98248a1070c657dd18099d77d225a1c169e52d3</originalsourceid><addsrcrecordid>eNpdkUtLAzEUhYMoKurKPzDgRpDRPCfJRtDSqlBRUNchk6R26kxSkxlL_73TB6LeTS6cL-cm5wJwiuAlIRJezUyDIIIYYbkDDjHkPIdEkN1f_QE4SWkG-xKCYsT3wQGhsJCQy0PQjVxdh0U-XLpsEJq5jlUKPitdu3DOZ89TbUL-WJkYpiF8ZDdl_uBbF33IXqMunenq0IZmmWlvt3D10jrf_sg6Zuvr-e1yrlPK1uox2JvoOrmT7XkE3kbD18F9Pn66exjcjHNDGW5zi7SwThImKdbYiJIWomAFhloKTIVGkENTMG4tElBKy7nFmGlkUCEdw5YcgeuN77wrG2dNPzrqWs1j1ei4VEFX6q_iq6l6D19KIMYRJb3B-dYghs_OpVY1VTJ9ZNq70CWFGSmogJSwHj37h85CF33_vRWFmRC4WBlebKg-kpSim_w8BkG12qj6tVHyDRogki4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532588263</pqid></control><display><type>article</type><title>Fellow-Eye Comparison between Phaco-Microhook Ab-Interno Trabeculotomy and Phaco-iStent Trabecular Micro-Bypass Stent</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Takayanagi, Yuji ; Ichioka, Sho ; Ishida, Akiko ; Tsutsui, Aika ; Tanito, Masaki</creator><creatorcontrib>Takayanagi, Yuji ; Ichioka, Sho ; Ishida, Akiko ; Tsutsui, Aika ; Tanito, Masaki</creatorcontrib><description>The aim of this study is to compare the surgical efficacy and safety between microhook ab-interno trabeculotomy (µLOT) and iStent trabecular micro-bypass stent implantation when both were combined with cataract surgery in both eyes of patients. Sixty-four glaucomatous eyes (32 participants; mean age, 75.9 ± 7.6 years; 15 men, 17 women) were included retrospectively. Intraocular pressure (IOP), number of antiglaucoma medications, best-corrected visual acuity (BCVA), anterior chamber flare (ACF) and corneal endothelial cell density (CECD) were evaluated preoperatively, as well as 2, 3, 6, and 12 months postoperatively. Surgical complications and interventions were compared between the procedures. The preoperative IOP and medications with µLOT (18.8 ± 5.7 mmHg and 3.0 ± 1.2, respectively) were higher than with the iStent (15.5 ± 3.4 mmHg and 2.7 ± 1.2, respectively) (p = 0.0001 and p = 0.0437, respectively). At 12 months, the µLOT values (12.6 ± 2.3 mmHg and 2.3 ± 0.9, respectively) were identical to iStent (12.8 ± 2.5 mmHg and 2.3 ± 0.9, respectively) (p = 0.0934 and p = 0.3251, respectively). At 12 months, the IOP decreased more with µLOT (6.2 mmHg, 29.5%) than iStent (2.7 mmHg, 15.6%) (p = 0.0003). The decrease in medications was greater with µLOT (0.7) than iStent (0.4) (p = 0.0437). Survival rate of IOP control ≤15 mmHg and IOP reduction ≥20% was significantly higher after µLOT (40.6% at 12 months) than iStent (18.8%) (p = 0.0277). The frequency of layered hyphema was significantly greater with µLOT (8 eyes, 25%) than iStent (0 eyes, 0%) (p = 0.0048). The increase in the ACF at 2 weeks postoperatively was significantly greater with µLOT than iStent (p = 0.0156), while changes in the BCVA and CECD were identical between groups. The fellow-eye comparison showed that the IOP reduction was greater with µLOT than iStent when combined with cataract surgery.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm10102129</identifier><identifier>PMID: 34069079</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Cataracts ; Clinical medicine ; Cornea ; Eye surgery ; Glaucoma ; Hospitals ; Pharmaceuticals ; Surgeons ; Surgical outcomes ; Viscoelasticity</subject><ispartof>Journal of clinical medicine, 2021-05, Vol.10 (10), p.2129</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-d1a8de935942a2c8b46865620a98248a1070c657dd18099d77d225a1c169e52d3</citedby><cites>FETCH-LOGICAL-c452t-d1a8de935942a2c8b46865620a98248a1070c657dd18099d77d225a1c169e52d3</cites><orcidid>0000-0001-6512-7203</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157143/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157143/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Takayanagi, Yuji</creatorcontrib><creatorcontrib>Ichioka, Sho</creatorcontrib><creatorcontrib>Ishida, Akiko</creatorcontrib><creatorcontrib>Tsutsui, Aika</creatorcontrib><creatorcontrib>Tanito, Masaki</creatorcontrib><title>Fellow-Eye Comparison between Phaco-Microhook Ab-Interno Trabeculotomy and Phaco-iStent Trabecular Micro-Bypass Stent</title><title>Journal of clinical medicine</title><description>The aim of this study is to compare the surgical efficacy and safety between microhook ab-interno trabeculotomy (µLOT) and iStent trabecular micro-bypass stent implantation when both were combined with cataract surgery in both eyes of patients. Sixty-four glaucomatous eyes (32 participants; mean age, 75.9 ± 7.6 years; 15 men, 17 women) were included retrospectively. Intraocular pressure (IOP), number of antiglaucoma medications, best-corrected visual acuity (BCVA), anterior chamber flare (ACF) and corneal endothelial cell density (CECD) were evaluated preoperatively, as well as 2, 3, 6, and 12 months postoperatively. Surgical complications and interventions were compared between the procedures. The preoperative IOP and medications with µLOT (18.8 ± 5.7 mmHg and 3.0 ± 1.2, respectively) were higher than with the iStent (15.5 ± 3.4 mmHg and 2.7 ± 1.2, respectively) (p = 0.0001 and p = 0.0437, respectively). At 12 months, the µLOT values (12.6 ± 2.3 mmHg and 2.3 ± 0.9, respectively) were identical to iStent (12.8 ± 2.5 mmHg and 2.3 ± 0.9, respectively) (p = 0.0934 and p = 0.3251, respectively). At 12 months, the IOP decreased more with µLOT (6.2 mmHg, 29.5%) than iStent (2.7 mmHg, 15.6%) (p = 0.0003). The decrease in medications was greater with µLOT (0.7) than iStent (0.4) (p = 0.0437). Survival rate of IOP control ≤15 mmHg and IOP reduction ≥20% was significantly higher after µLOT (40.6% at 12 months) than iStent (18.8%) (p = 0.0277). The frequency of layered hyphema was significantly greater with µLOT (8 eyes, 25%) than iStent (0 eyes, 0%) (p = 0.0048). The increase in the ACF at 2 weeks postoperatively was significantly greater with µLOT than iStent (p = 0.0156), while changes in the BCVA and CECD were identical between groups. The fellow-eye comparison showed that the IOP reduction was greater with µLOT than iStent when combined with cataract surgery.</description><subject>Cataracts</subject><subject>Clinical medicine</subject><subject>Cornea</subject><subject>Eye surgery</subject><subject>Glaucoma</subject><subject>Hospitals</subject><subject>Pharmaceuticals</subject><subject>Surgeons</subject><subject>Surgical outcomes</subject><subject>Viscoelasticity</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkUtLAzEUhYMoKurKPzDgRpDRPCfJRtDSqlBRUNchk6R26kxSkxlL_73TB6LeTS6cL-cm5wJwiuAlIRJezUyDIIIYYbkDDjHkPIdEkN1f_QE4SWkG-xKCYsT3wQGhsJCQy0PQjVxdh0U-XLpsEJq5jlUKPitdu3DOZ89TbUL-WJkYpiF8ZDdl_uBbF33IXqMunenq0IZmmWlvt3D10jrf_sg6Zuvr-e1yrlPK1uox2JvoOrmT7XkE3kbD18F9Pn66exjcjHNDGW5zi7SwThImKdbYiJIWomAFhloKTIVGkENTMG4tElBKy7nFmGlkUCEdw5YcgeuN77wrG2dNPzrqWs1j1ei4VEFX6q_iq6l6D19KIMYRJb3B-dYghs_OpVY1VTJ9ZNq70CWFGSmogJSwHj37h85CF33_vRWFmRC4WBlebKg-kpSim_w8BkG12qj6tVHyDRogki4</recordid><startdate>20210514</startdate><enddate>20210514</enddate><creator>Takayanagi, Yuji</creator><creator>Ichioka, Sho</creator><creator>Ishida, Akiko</creator><creator>Tsutsui, Aika</creator><creator>Tanito, Masaki</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6512-7203</orcidid></search><sort><creationdate>20210514</creationdate><title>Fellow-Eye Comparison between Phaco-Microhook Ab-Interno Trabeculotomy and Phaco-iStent Trabecular Micro-Bypass Stent</title><author>Takayanagi, Yuji ; Ichioka, Sho ; Ishida, Akiko ; Tsutsui, Aika ; Tanito, Masaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-d1a8de935942a2c8b46865620a98248a1070c657dd18099d77d225a1c169e52d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cataracts</topic><topic>Clinical medicine</topic><topic>Cornea</topic><topic>Eye surgery</topic><topic>Glaucoma</topic><topic>Hospitals</topic><topic>Pharmaceuticals</topic><topic>Surgeons</topic><topic>Surgical outcomes</topic><topic>Viscoelasticity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takayanagi, Yuji</creatorcontrib><creatorcontrib>Ichioka, Sho</creatorcontrib><creatorcontrib>Ishida, Akiko</creatorcontrib><creatorcontrib>Tsutsui, Aika</creatorcontrib><creatorcontrib>Tanito, Masaki</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takayanagi, Yuji</au><au>Ichioka, Sho</au><au>Ishida, Akiko</au><au>Tsutsui, Aika</au><au>Tanito, Masaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fellow-Eye Comparison between Phaco-Microhook Ab-Interno Trabeculotomy and Phaco-iStent Trabecular Micro-Bypass Stent</atitle><jtitle>Journal of clinical medicine</jtitle><date>2021-05-14</date><risdate>2021</risdate><volume>10</volume><issue>10</issue><spage>2129</spage><pages>2129-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>The aim of this study is to compare the surgical efficacy and safety between microhook ab-interno trabeculotomy (µLOT) and iStent trabecular micro-bypass stent implantation when both were combined with cataract surgery in both eyes of patients. Sixty-four glaucomatous eyes (32 participants; mean age, 75.9 ± 7.6 years; 15 men, 17 women) were included retrospectively. Intraocular pressure (IOP), number of antiglaucoma medications, best-corrected visual acuity (BCVA), anterior chamber flare (ACF) and corneal endothelial cell density (CECD) were evaluated preoperatively, as well as 2, 3, 6, and 12 months postoperatively. Surgical complications and interventions were compared between the procedures. The preoperative IOP and medications with µLOT (18.8 ± 5.7 mmHg and 3.0 ± 1.2, respectively) were higher than with the iStent (15.5 ± 3.4 mmHg and 2.7 ± 1.2, respectively) (p = 0.0001 and p = 0.0437, respectively). At 12 months, the µLOT values (12.6 ± 2.3 mmHg and 2.3 ± 0.9, respectively) were identical to iStent (12.8 ± 2.5 mmHg and 2.3 ± 0.9, respectively) (p = 0.0934 and p = 0.3251, respectively). At 12 months, the IOP decreased more with µLOT (6.2 mmHg, 29.5%) than iStent (2.7 mmHg, 15.6%) (p = 0.0003). The decrease in medications was greater with µLOT (0.7) than iStent (0.4) (p = 0.0437). Survival rate of IOP control ≤15 mmHg and IOP reduction ≥20% was significantly higher after µLOT (40.6% at 12 months) than iStent (18.8%) (p = 0.0277). The frequency of layered hyphema was significantly greater with µLOT (8 eyes, 25%) than iStent (0 eyes, 0%) (p = 0.0048). The increase in the ACF at 2 weeks postoperatively was significantly greater with µLOT than iStent (p = 0.0156), while changes in the BCVA and CECD were identical between groups. The fellow-eye comparison showed that the IOP reduction was greater with µLOT than iStent when combined with cataract surgery.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>34069079</pmid><doi>10.3390/jcm10102129</doi><orcidid>https://orcid.org/0000-0001-6512-7203</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2021-05, Vol.10 (10), p.2129
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8157143
source MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Cataracts
Clinical medicine
Cornea
Eye surgery
Glaucoma
Hospitals
Pharmaceuticals
Surgeons
Surgical outcomes
Viscoelasticity
title Fellow-Eye Comparison between Phaco-Microhook Ab-Interno Trabeculotomy and Phaco-iStent Trabecular Micro-Bypass Stent
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T17%3A08%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fellow-Eye%20Comparison%20between%20Phaco-Microhook%20Ab-Interno%20Trabeculotomy%20and%20Phaco-iStent%20Trabecular%20Micro-Bypass%20Stent&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Takayanagi,%20Yuji&rft.date=2021-05-14&rft.volume=10&rft.issue=10&rft.spage=2129&rft.pages=2129-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm10102129&rft_dat=%3Cproquest_pubme%3E2536480435%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2532588263&rft_id=info:pmid/34069079&rfr_iscdi=true